News
1 Attard, G., et al. (2025, May). Phase 3 AMPLITUDE trial: Niraparib and abiraterone acetate plus prednisone for metastatic castration-sensitive prostate cancer patients with alterations in homologous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback